tirzepatide heart disease How the weight loss drug is also helping failure patients 📌 Most viewed this week

You can read the full article at Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial In this study, researchers tested the effectiveness and safety of tesofensine, a drug that inhibits the uptake of certain neurotransmitters, in treating obesity

+How IGF-1 LR3 was discovered IGF-1 LR3 was engineered at GroPep in Australia in the late 1980s as a research-grade IGF-1 analogue with extended half-life and reduced binding-protein affinity

Women who are on fertility meds should not take a urine pregnancy test at all

Progranulin AAV gene therapy for frontotemporal dementia: Translational studies and phase 1/2 trial interim results

This may help to close the treatment gap between the effects of existing drugs and that of bariatric surgery on weight and metabolic parameters

doi: 10.1212/WNL.0b013e3182a393d1 114